Favaloro EJ - Search Results

1

Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment.

Hvas AM, Favaloro EJ, Hellfritzsch M. Hvas AM, et al. Among authors: favaloro ej. Expert Rev Hematol. 2021 Apr;14(4):335-346. doi: 10.1080/17474086.2021.1905512. Epub 2021 Mar 30. Expert Rev Hematol. 2021. PMID: 33736552 Review.

2

Heparin-induced thrombocytopenia: laboratory investigation and confirmation of diagnosis.

Favaloro EJ, Bernal-Hoyos E, Exner T, Koutts J. Favaloro EJ, et al. Pathology. 1992 Jul;24(3):177-83. doi: 10.3109/00313029209063169. Pathology. 1992. PMID: 1437290

3

How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspective.

Favaloro EJ, Bonar R, Aboud M, Low J, Sioufi J, Wheeler M, Lloyd J, Street A, Marsden K; RCPA QAP in Haematology. Favaloro EJ, et al. Lab Hematol. 2005;11(3):157-62. doi: 10.1532/LH96.05028. Lab Hematol. 2005. PMID: 16174600

4

Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors.

Favaloro EJ, Lippi G. Favaloro EJ, et al. Semin Thromb Hemost. 2015 Mar;41(2):208-27. doi: 10.1055/s-0035-1546827. Epub 2015 Feb 19. Semin Thromb Hemost. 2015. PMID: 25703514 Review.

5

Toward improved diagnosis of HIT.

Favaloro EJ. Favaloro EJ. Blood. 2015 Jul 30;126(5):563-4. doi: 10.1182/blood-2015-05-644740. Blood. 2015. PMID: 26228166 Free article. No abstract available.

6

The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.

Bonar R, Favaloro EJ, Mohammed S, Ahuja M, Pasalic L, Sioufi J, Marsden K. Bonar R, et al. Among authors: favaloro ej. Pathology. 2016 Jan;48(1):60-71. doi: 10.1016/j.pathol.2015.11.025. Epub 2015 Dec 17. Pathology. 2016. PMID: 27020211

7

Andexanet: Effectively Reversing Anticoagulation.

Lippi G, Sanchis-Gomar F, Favaloro EJ. Lippi G, et al. Among authors: favaloro ej. Trends Pharmacol Sci. 2016 Jun;37(6):413-414. doi: 10.1016/j.tips.2016.03.002. Epub 2016 Apr 2. Trends Pharmacol Sci. 2016. PMID: 27048885

8

Platelet function testing in pediatric patients.

Hvas AM, Favaloro EJ. Hvas AM, et al. Among authors: favaloro ej. Expert Rev Hematol. 2017 Apr;10(4):281-288. doi: 10.1080/17474086.2017.1293518. Epub 2017 Mar 2. Expert Rev Hematol. 2017. PMID: 28347215 Review.

9

Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update.

Favaloro EJ, McCaughan G, Pasalic L. Favaloro EJ, et al. Pathology. 2017 Jun;49(4):346-355. doi: 10.1016/j.pathol.2017.02.005. Epub 2017 Apr 23. Pathology. 2017. PMID: 28446364 Review.

10

Therapeutic monitoring of unfractionated heparin - trials and tribulations.

Baluwala I, Favaloro EJ, Pasalic L. Baluwala I, et al. Among authors: favaloro ej. Expert Rev Hematol. 2017 Jul;10(7):595-605. doi: 10.1080/17474086.2017.1345306. Expert Rev Hematol. 2017. PMID: 28632418 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

723 results

Search Page